Jeevan Scientific Technology Limited has filed its quarterly compliance certificate with BSE Limited, adhering to regulatory requirements under SEBI's depositories regulations. The submission relates to the quarter ended March 31, 2026, and confirms the company's compliance with securities dematerialization reporting obligations.

Regulatory Compliance Filing

The company submitted its compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 on April 14, 2026. Company Secretary and Compliance Officer Krishna Sainadh Kodati signed the certificate, which was addressed to the Head of Listing Operations at BSE Limited.

Registrar Confirmation

CIL Securities Limited, serving as the company's registrar and transfer agent, provided confirmation regarding dematerialization activities during the quarter. The registrar's letter dated April 6, 2026, formed the basis for the compliance certificate submission.

The registrar confirmed that no requests for dematerialization of shares were received from depositories during the quarter ended March 31, 2026. This confirmation was essential for completing the regulatory filing requirements.

Compliance Framework

Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 requires listed companies to furnish details of securities dematerialized during each quarter to all stock exchanges where their shares are listed. This regulatory framework ensures transparency in the dematerialization process and maintains accurate records of securities transactions.

The compliance certificate serves as formal documentation that the company has fulfilled its quarterly reporting obligations regarding securities dematerialization activities. Such filings are mandatory for all listed companies and form part of the broader regulatory compliance framework governing Indian capital markets.

Jeevan Scientific Technology Limited has disclosed a significant share transaction by its Executive Director under SEBI takeover regulations. The company filed the mandatory disclosure on March 30, 2026, following an off-market share sale by a key executive.

Share Transaction Details

Executive Director Nageswar Rao Yarlagadda sold 1,00,000 equity shares of the company through an off-market transaction on March 27, 2026. The disclosure was made under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Shareholding Changes

The transaction resulted in a significant reduction in Yarlagadda's stake in the company. His shareholding decreased from 1,33,900 shares to 33,900 shares following the sale.

Company Capital Structure

The company's equity share capital structure remained unchanged following the transaction. Jeevan Scientific Technology Limited maintains its total equity share capital at Rs. 19,91,89,650, divided into 1,99,18,965 fully paid-up equity shares of Rs. 10 each.

Regulatory Compliance

The disclosure was filed with BSE Limited, where the company's shares are listed. The Executive Director submitted a formal letter to the exchange along with the prescribed form under Regulation 29(2) of SEBI Takeover Regulations. The seller confirmed that he does not belong to the promoter or promoter group category. The documentation was signed and submitted from Hyderabad on March 30, 2026, ensuring full compliance with regulatory requirements.